391 related articles for article (PubMed ID: 26943320)
21. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
Javle M; Li Y; Tan D; Dong X; Chang P; Kar S; Li D
PLoS One; 2014; 9(1):e85942. PubMed ID: 24465802
[TBL] [Abstract][Full Text] [Related]
22. Methyl-CpG-binding domain 3 inhibits epithelial-mesenchymal transition in pancreatic cancer cells via TGF-β/Smad signalling.
Xu M; He J; Li J; Feng W; Zhou H; Wei H; Zhou M; Lu Y; Zeng J; Peng W; Du F; Gong A
Br J Cancer; 2017 Jan; 116(1):91-99. PubMed ID: 27898661
[TBL] [Abstract][Full Text] [Related]
23. The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells.
Arfmann-Knübel S; Struck B; Genrich G; Helm O; Sipos B; Sebens S; Schäfer H
PLoS One; 2015; 10(7):e0132978. PubMed ID: 26226105
[TBL] [Abstract][Full Text] [Related]
24. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
[TBL] [Abstract][Full Text] [Related]
25. microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions.
Ouyang H; Gore J; Deitz S; Korc M
Oncogene; 2014 Sep; 33(38):4664-74. PubMed ID: 24096486
[TBL] [Abstract][Full Text] [Related]
26. Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway.
Xu X; Zhao Z; Guo S; Li J; Liu S; You Y; Ni B; Wang H; Bie P
Cancer Lett; 2017 Jul; 397():12-22. PubMed ID: 28315433
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
28. TAp73 Inhibits EMT and Cell Migration in Pancreatic Cancer Cells through Promoting SMAD4 Expression and SMAD4-Dependent Inhibition of ERK Activation.
Ungefroren H; Konukiewitz B; Braun R; Wellner UF; Lehnert H; Marquardt JU
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568607
[TBL] [Abstract][Full Text] [Related]
29. Nox4-derived ROS signaling contributes to TGF-β-induced epithelial-mesenchymal transition in pancreatic cancer cells.
Hiraga R; Kato M; Miyagawa S; Kamata T
Anticancer Res; 2013 Oct; 33(10):4431-8. PubMed ID: 24123012
[TBL] [Abstract][Full Text] [Related]
30. Epithelial-mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine-rich alpha-2 glycoprotein.
Otsuru T; Kobayashi S; Wada H; Takahashi T; Gotoh K; Iwagami Y; Yamada D; Noda T; Asaoka T; Serada S; Fujimoto M; Eguchi H; Mori M; Doki Y; Naka T
Cancer Sci; 2019 Mar; 110(3):985-996. PubMed ID: 30575211
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia and Transforming Growth Factor β Cooperate to Induce Fibulin-5 Expression in Pancreatic Cancer.
Topalovski M; Hagopian M; Wang M; Brekken RA
J Biol Chem; 2016 Oct; 291(42):22244-22252. PubMed ID: 27531748
[TBL] [Abstract][Full Text] [Related]
32. TFEB-driven autophagy potentiates TGF-β induced migration in pancreatic cancer cells.
He R; Wang M; Zhao C; Shen M; Yu Y; He L; Zhao Y; Chen H; Shi X; Zhou M; Pan S; Liu Y; Guo X; Li X; Qin R
J Exp Clin Cancer Res; 2019 Aug; 38(1):340. PubMed ID: 31387632
[TBL] [Abstract][Full Text] [Related]
33. Anterior gradient 2 downregulation in a subset of pancreatic ductal adenocarcinoma is a prognostic factor indicative of epithelial-mesenchymal transition.
Mizuuchi Y; Aishima S; Ohuchida K; Shindo K; Fujino M; Hattori M; Miyazaki T; Mizumoto K; Tanaka M; Oda Y
Lab Invest; 2015 Feb; 95(2):193-206. PubMed ID: 25418581
[TBL] [Abstract][Full Text] [Related]
34. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
35. The interplay between TGF-β/SMAD and BMP/SMAD signaling pathways in the epithelial mesenchymal transition of A549 cells induced by silica.
Yu Y; Lin Y; Yang G; Tian L
Toxicol Mech Methods; 2018 May; 28(4):286-292. PubMed ID: 29161937
[TBL] [Abstract][Full Text] [Related]
36. Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells.
Liu F; Korc M
Mol Cancer Ther; 2012 Oct; 11(10):2138-48. PubMed ID: 22869556
[TBL] [Abstract][Full Text] [Related]
37. Adhesion and Rac1-dependent regulation of biglycan gene expression by transforming growth factor-beta. Evidence for oxidative signaling through NADPH oxidase.
Groth S; Schulze M; Kalthoff H; Fändrich F; Ungefroren H
J Biol Chem; 2005 Sep; 280(39):33190-9. PubMed ID: 16051607
[TBL] [Abstract][Full Text] [Related]
38. ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer.
Huang YH; Hu J; Chen F; Lecomte N; Basnet H; David CJ; Witkin MD; Allen PJ; Leach SD; Hollmann TJ; Iacobuzio-Donahue CA; Massagué J
Cancer Discov; 2020 Jan; 10(1):142-157. PubMed ID: 31582374
[TBL] [Abstract][Full Text] [Related]
39. Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function.
Wang P; Chen Z; Meng ZQ; Fan J; Luo JM; Liang W; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Xu ZD; Liu LM
Carcinogenesis; 2009 Sep; 30(9):1497-506. PubMed ID: 19546161
[TBL] [Abstract][Full Text] [Related]
40. Tumoral epithelial and stromal expression of SMAD proteins in pancreatic ductal adenocarcinomas.
Handra-Luca A; Hammel P; Sauvanet A; Ruszniewski P; Couvelard A
J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):294-302. PubMed ID: 22581056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]